Pfizer reports patient death in hemophilia trial for Hympavzi
Pfizer (PFE) on Tuesday announced that a patient who was taking part in a long-term extension trial for its hemophilia...
Tag: PFE
Bristol-Myers blood thinner Eliquis offered free to Medicaid as part of U.S. pricing deal
The U.S. government struck drug pricing deals with nine leading drugmakers on Friday, with the most notable among them being...
AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
Leading drugmakers, including AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead (GILD), and Merck (MRK), will be among the...
Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck’s Keytruda
Pfizer (PFE) and Astellas Pharma (ALPMY) announced on Wednesday that their antibody drug conjugate Padcev, with Merck’s...
Pfizer leads COVID-19 vaccine peers lower after revamped guidance
A slightly disappointing revenue outlook from Pfizer (PFE) was enough for its COVID-19 vaccine rivals Moderna (MRNA) and...
Pfizer reaffirms 2025 EPS guidance; adjusts revenue outlook
Ahead of a conference call with investment analysts on Tuesday, Pfizer (PFE) reaffirmed its 2025 outlook for adjusted...
FDA Commissioner Makary says ‘black box’ warning not coming to COVID vaccines
FDA Commissioner Marty Makary said the agency is not considering adding a "black box" warning -- the most serious kind for...
Pfizer declares $0.43 dividend
Pfizer (PFE) declares $0.43/share quarterly dividend, in line with previous. Forward yield 6.67% Payable March 6; for...
Pfizer in pact with China’s Fosun Pharma for oral GLP-1 drugs
Chinese drugmaker Fosun Pharma (SFOSF) on Tuesday announced a global licensing agreement with Pfizer (PFE) to hand the U.S....
Pfizer’s HYMPAVZI shows superior bleeding control in hemophilia Phase 3 Study
Pfizer (PFE) Saturday reported that its Phase 3 BASIS study demonstrated HYMPAVZI (marstacimab) significantly improved...